Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy

Paul G Thomes, Elizabeth Brandon-Warner, Ting Li, Terrence Donohue, Laura W. Schrum

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Our data describe autophagic flux in primary rat hepatic stellate cells (rHSCs) treated with pro-fibrotic growth factor, transforming growth factor beta (TGF-β). An autophagy flux experiment determines the rate of synthesis and degradation of the autophagosome marker, LC3-II in the presence and absence of the lysosomal inhibitor bafilomcyin, which blocks LC3-II degradation in lysosomes. The effects of a test agent on LC3-II flux through the autophagic pathway is determined immunochemically by its relative amounts detected in lysates of cells treated with and without bafilomycin. This measurement helps to validate whether exposure to an agent affects the biogenesis or the degradation of autophagosomes during autophagy, a major macromolecular degrading mechanism in eukaryotic cells. (“Rev-erb Agonist and TGF-β Similarly Affect Autophagy but Differentially Regulate Hepatic Stellate Cell Fibrogenic Phenotype” (Thomes et al., in press) [1].

Original languageEnglish (US)
Pages (from-to)312-314
Number of pages3
JournalData in Brief
Volume10
DOIs
StatePublished - Feb 1 2017

Fingerprint

experiment

ASJC Scopus subject areas

  • General

Cite this

Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy. / Thomes, Paul G; Brandon-Warner, Elizabeth; Li, Ting; Donohue, Terrence; Schrum, Laura W.

In: Data in Brief, Vol. 10, 01.02.2017, p. 312-314.

Research output: Contribution to journalArticle

Thomes, Paul G ; Brandon-Warner, Elizabeth ; Li, Ting ; Donohue, Terrence ; Schrum, Laura W. / Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy. In: Data in Brief. 2017 ; Vol. 10. pp. 312-314.
@article{b076a05a3ffb496c86c75d3d213cb990,
title = "Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy",
abstract = "Our data describe autophagic flux in primary rat hepatic stellate cells (rHSCs) treated with pro-fibrotic growth factor, transforming growth factor beta (TGF-β). An autophagy flux experiment determines the rate of synthesis and degradation of the autophagosome marker, LC3-II in the presence and absence of the lysosomal inhibitor bafilomcyin, which blocks LC3-II degradation in lysosomes. The effects of a test agent on LC3-II flux through the autophagic pathway is determined immunochemically by its relative amounts detected in lysates of cells treated with and without bafilomycin. This measurement helps to validate whether exposure to an agent affects the biogenesis or the degradation of autophagosomes during autophagy, a major macromolecular degrading mechanism in eukaryotic cells. (“Rev-erb Agonist and TGF-β Similarly Affect Autophagy but Differentially Regulate Hepatic Stellate Cell Fibrogenic Phenotype” (Thomes et al., in press) [1].",
author = "Thomes, {Paul G} and Elizabeth Brandon-Warner and Ting Li and Terrence Donohue and Schrum, {Laura W.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.dib.2016.12.005",
language = "English (US)",
volume = "10",
pages = "312--314",
journal = "Data in Brief",
issn = "2352-3409",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy

AU - Thomes, Paul G

AU - Brandon-Warner, Elizabeth

AU - Li, Ting

AU - Donohue, Terrence

AU - Schrum, Laura W.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Our data describe autophagic flux in primary rat hepatic stellate cells (rHSCs) treated with pro-fibrotic growth factor, transforming growth factor beta (TGF-β). An autophagy flux experiment determines the rate of synthesis and degradation of the autophagosome marker, LC3-II in the presence and absence of the lysosomal inhibitor bafilomcyin, which blocks LC3-II degradation in lysosomes. The effects of a test agent on LC3-II flux through the autophagic pathway is determined immunochemically by its relative amounts detected in lysates of cells treated with and without bafilomycin. This measurement helps to validate whether exposure to an agent affects the biogenesis or the degradation of autophagosomes during autophagy, a major macromolecular degrading mechanism in eukaryotic cells. (“Rev-erb Agonist and TGF-β Similarly Affect Autophagy but Differentially Regulate Hepatic Stellate Cell Fibrogenic Phenotype” (Thomes et al., in press) [1].

AB - Our data describe autophagic flux in primary rat hepatic stellate cells (rHSCs) treated with pro-fibrotic growth factor, transforming growth factor beta (TGF-β). An autophagy flux experiment determines the rate of synthesis and degradation of the autophagosome marker, LC3-II in the presence and absence of the lysosomal inhibitor bafilomcyin, which blocks LC3-II degradation in lysosomes. The effects of a test agent on LC3-II flux through the autophagic pathway is determined immunochemically by its relative amounts detected in lysates of cells treated with and without bafilomycin. This measurement helps to validate whether exposure to an agent affects the biogenesis or the degradation of autophagosomes during autophagy, a major macromolecular degrading mechanism in eukaryotic cells. (“Rev-erb Agonist and TGF-β Similarly Affect Autophagy but Differentially Regulate Hepatic Stellate Cell Fibrogenic Phenotype” (Thomes et al., in press) [1].

UR - http://www.scopus.com/inward/record.url?scp=85017306687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017306687&partnerID=8YFLogxK

U2 - 10.1016/j.dib.2016.12.005

DO - 10.1016/j.dib.2016.12.005

M3 - Article

VL - 10

SP - 312

EP - 314

JO - Data in Brief

JF - Data in Brief

SN - 2352-3409

ER -